Overview
KYBELLA® is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness, sometimes referred to as a “double chin.”
It is a common, yet under-treated facial aesthetic condition that can:
- Detract from an otherwise balanced and harmonious facial appearance
- Lead to an older and heavier look
- Impact a broad-range of adults, including both women and men
- Be caused by aging, genetics, and/or weight gain
KYBELLA® is a non-human and non-animal formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. It is administered by subcutaneous injections directly into submental fat.
When injected into subcutaneous fat, KYBELLA® causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved, retreatment is not expected.
